{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:41:13Z","timestamp":1782297673263,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1124\/jpet.123.001639","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T17:05:23Z","timestamp":1686589523000},"page":"242-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis"],"prefix":"10.1016","volume":"386","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-7576","authenticated-orcid":false,"given":"Davide","family":"Povero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Lazic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geza","family":"Ambrus-Aikelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Stansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina M.","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama F.","family":"Pranadinata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"McGeough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel E.","family":"Feldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Veal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001639_bib1","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/eji.201545655","article-title":"NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5","volume":"45","author":"Baker","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.123.001639_bib2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.chembiol.2017.08.011","article-title":"Boron-Based Inhibitors of the NLRP3 Inflammasome","volume":"24","author":"Baldwin","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1124\/jpet.123.001639_bib3","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001639_bib4","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1161\/ATVBAHA.117.310097","article-title":"The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology","volume":"37","author":"Baylis","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.123.001639_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"10.1124\/jpet.123.001639_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury","volume":"58","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1124\/jpet.123.001639_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"10.1124\/jpet.123.001639_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1124\/jpet.123.001639_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097136","article-title":"HCC development is associated to peripheral insulin resistance in a mouse model of NASH","volume":"9","author":"De Minicis","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001639_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molcel.2007.01.032","article-title":"Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation","volume":"25","author":"Faustin","year":"2007","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.123.001639_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1124\/jpet.123.001639_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human Monocytes Engage an Alternative Inflammasome Pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"key":"10.1124\/jpet.123.001639_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2016.10.007","article-title":"Alternative inflammasome activation enables IL-1\u03b2 release from living cells","volume":"44","author":"Gaidt","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1124\/jpet.123.001639_bib14","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.3748\/wjg.v20.i26.8525","article-title":"High fat diet feeding results in gender specific steatohepatitis and inflammasome activation","volume":"20","author":"Ganz","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1124\/jpet.123.001639_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2017.11.011","article-title":"An optimized whole blood assay measuring expression and activity of NLRP3, NLRC4 and AIM2 inflammasomes","volume":"191","author":"Grinstein","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1124\/jpet.123.001639_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/JIR.S141220","article-title":"Spotlight on the NLRP3 inflammasome pathway","volume":"11","author":"Groslambert","year":"2018","journal-title":"J Inflamm Res"},{"key":"10.1124\/jpet.123.001639_bib17","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.123.001639_bib18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"key":"10.1124\/jpet.123.001639_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and Regulation of NLRP3 Inflammasome Activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/jpet.123.001639_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.123.001639_bib21","doi-asserted-by":"crossref","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1124\/jpet.123.001639_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/acs.jafc.7b05113","article-title":"Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication","volume":"66","author":"Jhang","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1124\/jpet.123.001639_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcmgh.2022.06.007","article-title":"Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis","volume":"14","author":"Kaufmann","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1124\/jpet.123.001639_bib24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001639_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/jpet.123.001639_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","article-title":"Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy","volume":"8","author":"Kristiansen","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1124\/jpet.123.001639_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"10.1124\/jpet.123.001639_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/cr.2015.124","article-title":"Gasdermin D: the long-awaited executioner of pyroptosis","volume":"25","author":"Man","year":"2015","journal-title":"Cell Res"},{"key":"10.1124\/jpet.123.001639_bib29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.123.001639_bib30","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.cub.2004.10.027","article-title":"Identification of bacterial muramyl dipeptide as activator of the NALP3\/cryopyrin inflammasome","volume":"14","author":"Martinon","year":"2004","journal-title":"Curr Biol"},{"key":"10.1124\/jpet.123.001639_bib31","doi-asserted-by":"crossref","first-page":"14721","DOI":"10.1021\/acs.jmedchem.2c01250","article-title":"Overcoming Preclinical Safety Obstacles to Discover (S)-N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5 H-pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 Inhibitor","volume":"65","author":"McBride","year":"2022","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001639_bib32","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.4049\/jimmunol.1101737","article-title":"Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models","volume":"189","author":"McGeough","year":"2012","journal-title":"J Immunol"},{"key":"10.1124\/jpet.123.001639_bib33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.123.001639_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","article-title":"Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release","volume":"332","author":"Pan","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1124\/jpet.123.001639_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molmed.2016.12.007","article-title":"Inflammasome Priming in Sterile Inflammatory Disease","volume":"23","author":"Patel","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.123.001639_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00068-018-0956-1","article-title":"Macrophages play an essential role in trauma-induced sterile inflammation and tissue repair","volume":"44","author":"Peiseler","year":"2018","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1124\/jpet.123.001639_bib37","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","article-title":"Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation","volume":"197","author":"Primiano","year":"2016","journal-title":"J Immunol"},{"key":"10.1124\/jpet.123.001639_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001639_bib39","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/eji.201545772","article-title":"Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux","volume":"45","author":"R\u00fchl","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.123.001639_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fonc.2016.00151","article-title":"Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype","volume":"6","author":"Sallman","year":"2016","journal-title":"Front Oncol"},{"key":"10.1124\/jpet.123.001639_bib41","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/eji.201545523","article-title":"Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells","volume":"45","author":"Schmid-Burgk","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.123.001639_bib42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1124\/jpet.123.001639_bib43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","article-title":"Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays","volume":"147","author":"Shah","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.123.001639_bib44","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.4049\/jimmunol.1301539","article-title":"Processes of sterile inflammation","volume":"191","author":"Shen","year":"2013","journal-title":"J Immunol"},{"key":"10.1124\/jpet.123.001639_bib45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001639_bib46","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.123.001639_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3748\/wjg.v24.i2.179","article-title":"Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis","volume":"24","author":"T\u00f8lb\u00f8l","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1124\/jpet.123.001639_bib48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/CIRCRESAHA.117.311984","article-title":"CANTOS Trial Validates the Inflammatory Pathogenesis of Atherosclerosis: Setting the Stage for a New Chapter in Therapeutic Targeting","volume":"121","author":"Weber","year":"2017","journal-title":"Circ Res"},{"key":"10.1124\/jpet.123.001639_bib49","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1124\/jpet.123.001639_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"10.1124\/jpet.123.001639_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063759","article-title":"Adenosine-5\u2032-triphosphate (ATP) protects mice against bacterial infection by activation of the NLRP3 inflammasome","volume":"8","author":"Xiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001639_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"}],"updated-by":[{"DOI":"10.1124\/jpet.123.001639err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:30:25Z","timestamp":1739971825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524170693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022356524170693"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001639","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.123.001639err","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}